This online webinar will cover:

• Bowel Cancer in NSW

• The National Bowel Cancer Screening Program 

– Current and projected participation and impact on bowel cancer deaths 

– Economic impact of treating later stage bowel cancer

• Colonoscopy demand in SVHN (modelling) 

• The challenge: providing access to timely colonoscopy 

• Value based healthcare & Leading Better Value Care

– Shifting from volume to value

– Leading Better Value Care Program 

• The Direct Access colonoscopy initiative 

• Direct access colonoscopy at SVHN 

There is a substantial shift towards earlier stage diagnosis and prevention of bowel cancer related deaths through participation in the National Bowel Cancer Screening Program (NBCSP). A reduction in the number of bowel cancer cases and the number of deaths attributed to bowel cancer leads to reduced costs of treatment. To continue to reduce the incidence of bowel cancer and reduce health care costs, people require access to timely, high quality colonoscopy. 

Over the past 18 months, SVHN has developed a DAC model which aims to reduce unnecessary delays for someone where the diagnosis-of-exclusion is now cancer. DAC enables patients who fulfil a set clinical criteria to attend once, on the day of their procedure without the need for a specialist consultation. In a DAC model, GP’s are often the first point of contact for a person following a positive iFOBT and are responsible for initiating the DAC journey for people by referring them directly into a DAC service. 

Target audience: GPs and Practice Managers

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991